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Sesto Fiorentino, ItalyABSTRACT Dehaloperoxidase (DHP) from the annelid Amphitrite ornata is a catalytically active hemoglobin-peroxidase that
possesses a unique internal binding cavity in the distal pocket above the heme. The previously published crystal structure of
DHP shows 4-iodophenol bound internally. This led to the proposal that the internal binding site is the active site for phenol oxida-
tion. However, the native substrate for DHP is 2,4,6-tribromophenol, and all attempts to bind 2,4,6-tribromophenol in the internal
site under physiological conditions have failed. Herein, we show that the binding of 4-halophenols in the internal pocket inhibits
enzymatic function. Furthermore, we demonstrate that DHP has a unique two-site competitive binding mechanism in which the
internal and external binding sites communicate through two conformations of the distal histidine of the enzyme, resulting in
nonclassical competitive inhibition. The same distal histidine conformations involved in DHP function regulate oxygen binding
and release during transport and storage by hemoglobins and myoglobins. This work provides further support for the hypothesis
that DHP possesses an external binding site for substrate oxidation, as is typical for the peroxidase family of enzymes.INTRODUCTIONThe two dehaloperoxidase (DHP) hemoglobins (Hbs) from
Amphitrite ornate, DHP A and DHP B, are the first charac-
terized Hbs that have natural peroxidase function (1–6).
Hbs, including DHP, are readily identified by their charac-
teristic 3/3 a-helical protein structure. Although Hbs are
primarily associated with O2 storage and transport, the char-
acteristic globin fold actually encodes a diversity of protein
functions. In addition to allosteric regulation of oxygen
uptake, globins minimize the autooxidation rate of the
heme iron, discriminate against CO binding, and carry out
other natural functions such as NO binding and oxidation
to nitrate. DHP brings this functional diversity to a new level
by combining the seemingly contradictory functions of
reversible oxygen binding (globin) and hydrogen peroxide
activation (peroxidase).
Although Hbs and heme peroxidases are structurally
distinct and perform different functions, they have
a common heme cofactor and iron-binding site, with a histi-
dine residue positioned on each side (Fig. 1). The proximal
histidine is coordinated to the heme iron and provides
a charge relay that supports either the ferrous (Fe2þ) or
ferric (Fe3þ) iron oxidation state (7,8) depending on the
local environment of globins or peroxidases, respectively.
In myoglobins (Mbs) and Hbs, the distal histidine stabilizes
diatomic oxygen during uptake and transport, whereas in
peroxidases, the distal histidine serves as the acid-base cata-
lyst necessary for heterolytic O-O bond cleavage, which
constitutes the activation of bound hydrogen peroxide. Allo-Submitted March 4, 2010, and accepted for publication May 17, 2010.
*Correspondence: Stefan_Franzen@ncsu.edu
Editor: Patrick Loria.
 2010 by the Biophysical Society
0006-3495/10/09/1586/10 $2.00stery in Hb is vital for the proper uptake of oxygen in the
lungs and release of oxygen to respiring tissues (9). Whereas
allostery may modify a binding constant or facilitate
communication between multimers in cooperative proteins
such as Hb, allosteric inhibition in heme peroxidases is an
off-switch that can cause the enzyme to become completely
inactive (10–12). The significance of both allostery and inhi-
bition is more complex in a dual-function protein like DHP
because the regulation involves not only each individual
function, but also the switch between functions.
The first x-ray crystal structures of DHP A (Protein Data
Bank (PDB) 1EW6 and 1EWA), obtained at room tempera-
ture, showed two features that are unique in the Hb super-
family (1). First, the distal histidine was observed in two
conformations at pH 6, identified as open or closed. The
closed conformation is the commonly observed conforma-
tion shown in Fig. 2 a, in which the histidine is in the distal
pocket and interacts with a ligand coordinated to the heme
iron (13). In the open conformation (Fig. 2 b), the distal
histidine (H55) has swung out to a solvent-exposed position
(14). Although the open conformation is known in sperm
whale Mb, it is only observed below pH 4.5 when the distal
histidine is protonated (15). We previously showed by
a comparison of x-ray crystal structures (3DR9 and
2QFK) at 100 K that the open and closed conformations
in DHP A are correlated with the 5-coordinate (5c) and
6-coordinate (6c) forms of the heme iron, respectively
(13,14). Furthermore, the unique flexibility of the distal
histidine has been shown to play an important role in
heme-coordinated ligand stabilization (16). The second
unprecedented observation in the initial x-ray crystal











































































FIGURE 1 Reaction scheme emphasizing the conformation of the distal
histidine, H55, in response to binding of the substrate, 2,4,6-TXP, and
inhibitor, 4-XP. (a) Active enzyme: DHP with TXP substrate bound
external to the heme pocket. The protein is 6cHS (aquo) with the distal
H55 in a closed position. (b) When an inhibitor (4-XP) binds in the internal
pocket of DHP, H2O is displaced (5cHS) and the distal H55 is pushed to the
open position. The resulting conformation leads to inactivation of the
enzyme. (c) Addition of H2O2 leads to the formation of compound ES
(39), the high-valent iron-oxo protein (Tyr) radical intermediate, which
can lead to formation of the product 2,6-DXQ by two-electron oxidation.
Compound ES cannot be formed in the inhibitor-bound state because the
FeIII site is blocked by 4-XP binding in the distal cavity. (d) In the resting
state of DHP the distal histidine exists in two conformations, known as open
(black) and closed (gray). H2O is bound to the heme iron only in the closed
conformation.
Internal Binding Inhibits DHP 15874-iodophenol, in a well-defined position in the distal pocket
of the globin but not coordinated to the heme iron (1). This
unusual mode of binding in an Hb led to the suggestion that
the internal binding site is the substrate-binding site (1).
We have systematically investigated this hypothesis and
found that the 4-halogenated phenols (4-XP) that bind
internally are inhibitors rather than substrates. The active








b(2,4,6-TBP), 2,4,6,-trichlorophenol (2,4,6-TCP), and 2,4,6,-
trifluorophenol (2,4,6-TFP) is external (17). The possibility
that an external substrate-binding site is located on DHP A
was recently established via backbone NMR experiments
(18). Given the extensive data available on DHP A relative
to the more recently characterized DHP B, the remainder
of this study will focus on DHP A, which will be referred
to as DHP for brevity.
In this work, we provide detailed evidence that internal
binding of 4-XPs inhibits the peroxidase function of DHP.
This result is contradictory to the previous hypothesis that
the distal pocket binding site for 4-XP is the substrate-
binding site for phenol oxidation. This work builds on
a number of observations that support the existence of
distinct binding sites for 4-BP and 2,4,6-TBP, and demon-
strates that these distinct sites are involved in inhibition
of a competitive nature. Normally, competitive inhibition
implies that the substrate and inhibitor compete for the
same binding site. However, the structural and kinetic
evidence presented below suggests that DHP exhibits
a form of competitive inhibition (formally known as
allosteric or nonclassical competitive inhibition (19–22))
in which the inhibitor binds remote to the active site and
creates a conformational change in the enzyme that prevents
the substrate from binding. The x-ray crystallographic, reso-
nance Raman (RR), and kinetic data presented here are
consistent with competitive inhibition between the internal
and external sites mediated by the distal histidine (H55).
The proposed functional role for the distal histidine, as the
switch that leads to peroxidase inhibition (open) and activa-
tion (closed), underlies the regulation of oxygen-binding
affinity by the same histidine in the open (low affinity)
and closed (high affinity) conformations traditionally
observed in globins (15,23,24).MATERIALS AND METHODS
Materials
Buffer salts were purchased from Fisher Scientific (Waltham, MA).
All other reagents were purchased from Sigma-Aldrich (St. Louis, MO)
and used without further purification.FIGURE 2 X-ray crystal structures of DHP at
100 K. (a) The metaquo form shows a hydrogen-
bond interaction between the distal histidine
(H55) and the water molecule coordinated to the
ferric heme iron (PDB 2QFK; closed conforma-
tion). (b) The deoxy form has a pentacoordinate
heme iron. Two rotamers of H55 are observed in
which H55 appears exclusively in a solvent-
exposed conformation (PDB 3DR9). This His
conformer corresponds to the open form observed
in Mb at pH 4.5 (15). (c) The three structures of
4-IP (3LB1, green), 4-BP (3LB2, light blue), and
4-CP (3LB3, gray) bound in the distal pocket of
DHP are superimposed. 4-FP (3LB4) is not shown
in the figure (see text).
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TABLE 1 Data collection and refinement statistics
I* Br* Cl* F*
PDB code 3LB1 3LB2 3LB3 3LB4
Space group P212121 P212121 P212121 P212121
Unit-cell parameters
a (A˚) 57.84 58.01 58.20 59.78
b (A˚) 67.25 67.36 67.21 67.49
c (A˚) 69.13 69.42 68.72 67.84
Data collection
Temperature (K) 100 100 100 100
Wavelength (A˚) 1.5000 0.91942 1.0000 1.0000
Resolution (A˚) 35.0–1.76 35.0–1.06 35.0–1.85 35.0–1.56
(1.81–1.76)y (1.09–1.06)y (1.90–1.85)y (1.60–1.56)y
Unique
reflections
25737(1737)y 121970(8490)y 22277(15730)y 33583(2740)y
Completeness (%) 94.24(87.82)y 98.67(93.80)y 94.25(92.91)y 94.03(95.34)y
Rmerge
z (%) 4.1(9.8) 5.2(31.8) 10.1(32.2) 6.1(38.3)
I/sI 37.9(13.2)y 22.5(3.8)y 7.9(3.4)y 10.9(3.9)y
Redundancy 3.5(3.4)y 4.0(3.3)y 3.4(3.4)y 3.1(3.3)y
Refinement
Rwork/Rfree (%)
x 18.6/22.7 16.8/18.3 18.7/24.3 19.5/23.5
Average B factor (A˚2)
All atoms 12.73 10.16 19.13 17.19
Protein 11.81 8.98 18.55 15.19
Water 21.59 20.21 30.35 28.75
No. of atoms
Protein 2658 3122 2192 2849
Water 268 356 213 299
RMSD from ideal
Bond length (A˚) 0.008 0.006 0.008 0.011
Bond angle (deg) 1.124 1.170 1.157 1.377
Ramachandran plot{ (%)
Most favored 94.4 94.4 94.4 94.8
Allowed 5.6 5.6 5.6 5.2
*Crystal containing 4-halophenol in complex with WT DHP; the letter specifies the halogen substituent.
yValues in parentheses are the highest-resolution shell.
zRmerge¼ (ShSi{}  100%, where Ii is the ith measurement and <I(h)> is the weighted mean of all measurements of I(h).
xRwork ¼ SjFo  Fcj/SFo  100%, where Fo and Fc are observed and calculated structure factors, respectively; Rfree is R factor for the subset (5%) of reflec-
tions selected before, and not included in the refinement.
{Calculated using PROCHECK.
1588 Thompson et al.Crystallization, data collection, and processing
Recombinant wild-type (WT) protein was expressed in E. coli, purified, and
characterized as previously described (13). To obtain crystals of DHP com-
plexed with substrate analogs, the protein, at a concentration of 8 mg/mL
dissolved in 10 mM Na cacodylate pH 6.5, was incubated on ice for
30 min with the parahalogenated phenols (1.5 mM 4-IP, 10 mM 4-BP, or
10 mM 4-CP, respectively) and crystallized using the hanging drop vapor
diffusion method, with the reservoir solution containing unbuffered
0.2 M ammonium sulfate and 32% PEG 4000 (w/v) as described previously
(13,14). The crystals were cryoprotected in a solution containing 0.2 M
ammonium sulfate, 35% PEG 4000 (w/v), and 15% PEG 400 as the cryo-
protectant. Data were collected at 100 K on the SER-CAT 22-ID beamline
at the APS synchrotron facility using a wavelength of 1 A˚ for crystals
derivatized with 4-chloro- and 4-fluorophenol, 0.91942 A˚ for crystals
derivatized with 4-bromophenol, and 1.5 A˚ for crystals derivatized with
4-iodophenol. The latter two wavelengths were chosen so that two data
sets could be collected in a single-wavelength anomalous dispersion
mode to correctly orient the halogenated phenol in its electron density.
The collected diffraction data sets were processed using the HKL2000
program suite (25). The new crystals belong to the same space group
(P212121) as the ferric water-ligated (metaquo) form (PDB entry 2QFK),
and the structures were solved by molecular replacement using 2QFK coor-Biophysical Journal 99(5) 1586–1595dinates as a starting model in the Phaser molecular replacement program
(26). Structure determination and refinement calculations were performed
using the CCP4 suite of programs (27,28), and visualization and manual
model building were conducted using Coot model building software (29).
Waters were placed with the Coot routine Find Waters using 2Fo-Fc
contoured at the 1s level, and Fo-Fc maps at the 3s level. The occupancies
were refined manually until no residual Fo-Fc density remained. Final
models were obtained by iterative cycles of model building in Coot using
2Fo-Fc (contoured at the 1s level) and Fo-Fc electron density maps (con-
toured at the 3s level), and positional and anisotropic B factor structure
refinement using Refmac5 (30) in the CCP4 suite of programs (31) and
CNS (32). Simulated annealing and composite omit maps were constructed
with the CNS program. All of the figures were prepared using VMD (33).
The refinement statistics of the four x-ray crystal structures (3LB1, 3LB2,
3LB3, and 3LB4) are given in Table 1.Electronic absorption spectroscopy
and kinetic assays
Recombinant his-tagged WT protein was expressed in Escherichia coli and
purified as previously described (17,18). Initial inhibition experiments were
conducted in 100 mM potassium phosphate buffer at pH 7 using an Agilent
Internal Binding Inhibits DHP 15898453 UV-vis spectrometer equipped with a temperature control and Hewlett
Packard UV-Visible Chemstation software set to kinetics mode. The
concentration of DHP in each sample was ~2.4 mM and the temperature
was equilibrated to 20C. A 100-fold excess of H2O2 (240 mM) was added
to the cuvette to initiate the assay. Electronic absorption spectra were taken
every 2 s for 2 min, monitoring the 273 nm peak of the 2,6-dichloro-1,4-di-
benzoquinone (2,4-DCQ) product. The assays were repeated with the addi-
tion of 250 mM4-bromophenol in each sample to demonstrate the inhibition
effect.
Inhibition assays for Michaelis-Menten analysis were conducted on
a Cary 100 UV-vis equipped with a Cary temperature control system and
an Applied Photophysics RX2000 rapid kinetics spectrometer accessory.
The Applied Photophysics premixing chambers were temperature-
controlled with a Fisher Scientific Isotemp 3006S set to 25C. Instruments
were controlled by Cary WinUV software in kinetics mode set to monitor
the 273 2,4-DCQ peak every 0.1 s for 60 s. Assay conditions were 2 mM
DHP initiated with 2 mM H2O2 in 100 mM potassium phosphate buffer
at pH 7. Eight assays were completed at each of the 2,4,6-TCP concentra-
tions. The assays were then repeated at each of the 2,4,6-TCP
concentrations with the presence of 125, 250, and 500 mM 4-BP. The initial
velocity, Vo, of enzyme turnover was obtained for each concentration of the
2,4,6-TCP substrate and the 2,4,6-TCP substrate with inhibitor. The Vo
versus 2,4,6-TCP concentration data were fit independently to the Michae-
lis-Menten equation using nonlinear least squares in Igor Pro 5.0.RR spectroscopy
All protein samples used in the RR experiments were purified as above and
maintained in 150 mM potassium phosphate buffer, pH 6. The final protein
concentration for all RR samples was 100 mM. Parahalogenated substrate
analogs were introduced to final concentrations of 8 mM for 4-BP, 4-CP,
4-FP, and phenol, and to 1 mM for 4-IP (the concentration of 4-IP is limited
by its low solubility at 25C). The samples were placed into 5-mm-diameter
glass NMR tubes and stored on ice until used.
RR spectra were obtained by Soret band excitation using a Coherent Mira
900 titanium sapphire (Ti:sapphire) laser. The Ti:sapphire laser was
pumped using a Coherent Verdi 10 frequency-doubled diode-pumped
Nd:vanadate laser generating 10 W at 532 nm. The beam generated from
the Ti:sapphire is tunable through ~700–1000 nm, and was sent through
a Coherent 5-050 doubler to generate a normal working range of
400–430 nm for Soret band excitation. The beam was collimated and cylin-
drically focused to a vertical line of ~0.5 mm on the sample. Scattered light
was collected with a Spex 1877 triple spectrometer (2400 grooves/mm final
stage grating) equipped with an ISA SPEX liquid nitrogen-cooled CCD at
~1.7 cm1 resolution. Computer acquisition of the data was accomplished
with SpectraMax 2.0 software. The spectra were calibrated using known
peaks from indene, toluene, and carbon tetrachloride standards.Binding isotherm analysis
A titration data set for each inhibitor binding to DHP was collected via
a series of RR spectra. Each sample contained 100 mM DHP in 150 mM
potassium phosphate buffer at pH 6, with concentrations of the inhibitor
from 0 to 8 mM (0–1 mM for 4-IP only). Singular value decomposition
(SVD) was performed on the spectral data set with the use of Igor Pro
5.0. The SVD analysis yields one-dimensional column and row eigenvec-
tors, with columns corresponding to changes with respect to wavenumber,
and rows corresponding to changes with respect to concentration. The SVD
row eigenvectors representing the intensity changes and the peak shifts of
the Raman data set were fit using nonlinear least-squares to the single-
site binding equation
q ¼ ½I
Kd þ ½Ito determine apparent substrate dissociation constants, Kd, where q is the
fraction 5c high spin (5cHS) protein and [I] is the concentration of inhibitor.RESULTS
Crystallography
Previously published x-ray crystal structures (13,14) and
spectroscopic data (16) strongly suggest a role for distal
histidine flexibility in DHP. Fig. 2, a (closed) and
b (open), shows PDB structures 2QFK and 3DR9, respec-
tively. As mentioned above, in the metaquo form, the distal
His is stabilized in the closed conformation by hydrogen
bonding to the heme-coordinated water molecule (Fig. 2 a),
and the heme iron is 6c high spin (6cHS). However, unlike
other Hb structures (34–36), in the 5c deoxy form, the His is
observed in the open conformation (Fig. 2 b). Therefore, the
open and closed conformations in DHP are correlated with
the 5c and 6c forms of the heme iron. Fig. 2 c shows an
overlay of the new heme pocket structures of DHP cocrys-
tallized with 4-IP (3LB1), 4-BP (3LB2), and 4-CP (3LB3)
following established protocols (13). The 4-XPs bind in
a conformation close to that originally reported for 4-IP
(1). The occupancy of the 4-IP, 4-BP, and 4-CP molecules
is >90% in all three structures. The structure of DHP with
4-FP (3LB4) is not shown, due to its low occupancy
(<50%) and for clarity of the figure. Upon binding of these
molecules in the internal site, the heme-coordinated water
molecule is displaced and the histidine is pushed into
the open conformation; thus, the iron is 5cHS (see also
Fig. 1 for a schematic). The secondary structure of DHP A
exhibits remarkably little change when 4-XPs bind in the
distal pocket. The backbone root mean-square deviations
(RMSDs) from the metaquo structure are ~%0.4 A˚, and
the pairwise main-chain differences between the complexed
structures are on the order of 0.1–0.2 A˚. On the other hand,
superposition of the structures shows that as the size of the
parahalogen atom increases, the position of the 4-XP mole-
cules bound in the distal pocket shifts slightly toward the
heme-7-propionate and the solvent-exposed distal histidine.Binding of parahalogenated phenols
In this study, the x-ray crystal structures provided meaning-
ful insight into DHP in the solid state, whereas RR spectros-
copy revealed the solution-state properties of halophenol
binding. Fig. 3 a compares the RR spectra of WT-DHP
with those obtained upon addition of phenol, and the 4-XP
molecules (X ¼ F, Cl, Br, I). The 5cHS core size marker
band frequencies (n3 at 1494 cm
1, n2 at 1568 cm
1, and
n10 at 1632 cm
1) systematically become more intense at
the expense of the aquo 6cHS heme state (n3 at 1481 cm
1,
n2 at 1562 cm
1, and n10 at 1611 cm
1) for the series of
4-XP bound DHP relative to WT-DHP. Similar systematic
changes are also observed in the corresponding electronic
absorption spectra. The Soret maximum undergoesBiophysical Journal 99(5) 1586–1595
FIGURE 3 Determination of internal binding affinity. (a) RR core size
marker band region for WT-DHP (black), DHP with phenol (yellow),
DHP with 4-FP (purple), DHP with 4-CP (blue), DHP with 4-BP (green),
and DHP with 4-IP (red). The n2, n3, and n10 frequencies are consistent
with the increase of a 5cHS iron upon addition of the inhibitors. The final
concentration of 4-IP was 1 mM (maximum solubility), and the final
concentration of 4-BP, 4-CP, 4-FP, and phenol was 8 mM. Protein concen-
tration: 100 mM; excitation wavelength: 406 nm; resolution: 1.7 cm1; laser
power at the sample: 60 mW; acquisition time: 300 s. (b) Binding isotherms
for 4-IP (red), 4-BP (green), 4-CP (blue), 4-FP (purple), and phenol
(yellow). The isotherms clearly establish that the affinity of DHP for






FIGURE 4 Evidence of external binding. RR core size marker band
region for WT-DHP (a), DHP with 2,4,6-TBP (b), DHP with 2,4,6-TCP
(c), and DHP with 2,4,6-TFP (d). The n2, n3, and n10 frequencies shift to
predominantly 6cHS upon addition of the TXP substrates. The 5cHS pop-
ulation observed upon addition of 2,4,6-TFP may indicate that 2,4,6-TFP
does enter the distal pocket to some degree, in agreement with cryogenic
experiments (16,37,38). The final concentration of 2,4,6-TBP was
200 mM, and the final concentrations of 2,4,6-TCP and 2,4,6-TFP were
4 mM in 150 mM potassium phosphate buffer, pH 6. Excitation wavelength:
406 nm; resolution: 1.7 cm1; laser power at the sample: 60 mW; acquisi-
tion time: 300 s.
1590 Thompson et al.a systematic blue shift as the substrate halogen is changed
and follows the halogen series (see Fig. S1 in the Supporting
Material). Therefore, in agreement with the x-ray crystal
structures, binding of 4-XP in the internal pocket is consis-
tent with the loss of the 6cHS population and subsequent
movement of the distal His to the open, solvent-exposed
position. Fig. 3 b shows that 4-halophenols bind in the distal
pocket with a binding affinity that follows the trend I> Br>
Cl > F > H, with apparent dissociation constants of 0.536,
1.15, 1.78, 3.72, and 10.0 mM, respectively. We use the termBiophysical Journal 99(5) 1586–1595‘‘apparent dissociation constant’’ because the binding
isotherms represent the fraction of enzyme that is converted
to 5cHS, which does not necessarily reflect total binding to
the enzyme. The relative binding affinity of 4-FP reflects its
low occupancy in the crystal structure. The binding
isotherms were determined using the change in relative
intensities and the frequency shifts of the core size heme
vibrational modes measured by RR spectroscopy and
obtained from the data shown in Fig. 3 a by SVD (as shown
in Fig. S2).Binding of trihalogenated phenols
In contrast to the binding of 4-XPs, binding of 2,4,6-TXP
substrates produces an increase of the 6cHS species. Fig. 4
shows the change of the RR core size marker bands,
indicating the formation of a predominantly 6cHS heme
(n3 at 1481 cm
1, n2 at 1562 cm
1, and n10 at 1611 cm
1)
when 2,4,6-TBP and 2,4,6-TCP bind to DHP. Although the
binding of 2,4,6-TFP also produces predominantly 6cHS
heme, an appreciable amount of 5cHS (n3 at 1494 cm
1,
Internal Binding Inhibits DHP 1591n2 at 1568 cm
1, and n10 at 1632 cm
1) is also formed, indi-
cating that, unlike 2,4,6-TCP or 2,4,6-TBP, 2,4,6-TFP binds
either externally or internally. This result is in agreementwith
previous studies of DHP showing that 2,4,6-TFP binds inter-
nally at cryogenic temperatures (16,37,38) but binds nonspe-
cifically to both sites at room temperature (16,18). The
corresponding electronic absorption spectra of 2,4,6-TXP
binding (Fig. S3) change accordingly. Of greater importance,
we can control the distal histidine and force DHP to adopt
either the 5cHS or 6cHS state by changing the concentrations
of 4-BP and 2,4,6-TCP present in solution. Fig. S4 shows that
the same ratio of 5cHS/6cHS heme is achieved by first adding
DHP to 2,4,6-TCP and then adding 4-BP, or by first adding
DHP to 4-BP and then adding 2,4,6-TCP. The result demon-
strates that 2,4,6-TCP and 4-BP compete for their respective
binding locations until an equilibrium between the two states
is attained. The x-ray crystal structures show the mutual
exclusivity of the closed conformation of the distal histidine
and the binding of 4-XP in the distal pocket. Since binding of
2,4,6-TCP forces the distal histidine into the closed position,
it must also effectively remove 4-BP from the distal pocket.
Thus, by correlation of the x-ray crystal structures and the
RR data, we conclude that binding at the internal site and
binding at the external site are mutually exclusive events.Enzyme inhibition by parahalogenated phenols
Davis et al. (18) confirmed the existence of two distinct
binding sites for 2,4,6-TCP and 4-BP, and showed that DHP
has little activity toward 4-BP compared to 2,4,6-TCP.dc
a b
e fWe therefore tested the effect of internal binding of 4-XP on
the turnover of 2,4,6-TCP. Fig. 5 provides kinetic evidence
that the oxidation of 2,4,6-TCP is in fact inhibited by internal
binding of 4-halophenols. The substrate (2,4,6-TCP) is
readily converted to product (2,6-DCQ) when DHP is acti-
vated with excess H2O2 (Fig. 5 a). However, in the presence
of even a 2:1 ratio of 4-XP/2,4,6-TCP, little turnover of
2,4,6-TCP to 2,6-DCQ is observed (Fig. 5, b–e). In fact, the
only appreciable turnover is observed in the presence of
4-FP, in agreement with the binding isotherms from Fig. 2 b
that suggest only a small fraction of 4-FP binds internally.
Since the 4-XP molecules bind internally and force the distal
histidine to adopt the open conformation, it is likely that they
prevent the formation of compound ES (39), the H2O2 acti-
vated protein radical form of DHP that is analogous to
compound I of cytochrome c peroxidase (40) (see Fig. 1 c).
Indeed, Fig. 5 f shows that increasing the concentration of
4-BP systematically blocks the formation of compound ES.Michaelis-Menten inhibition/kinetic analysis
Since the unique internal binding of 4-XPs inhibits the
peroxidase function of DHP at a remote external site, it is
of interest to determine the type of inhibition that occurs
between the two sites. The solubility of the native substrate,
2,4,6-TBP, is relatively low (~200 mM), which limits its
usefulness for kinetic studies. However, 2,4,6-TCP is an
excellent substrate and has higher solubility than 2,4,6-
TBP. Therefore, we used 2,4,6-TCP rather than 2,4,6-TBP
for the subsequent kinetic studies to demonstrate enzymaticFIGURE 5 Kinetic assays showing inhibition by
internally bound 4-XPs. (a–e) Time-dependent
UV-Vis spectra from 0 s (red) to 120 s (purple).
In the absence of 4-XP (a), the TCP substrate
(312 nm) is converted to the DCQ product
(273 nm). In the presence of 4-IP, 4-BP, and
4-CP (b–d), little product is formed, with no signif-
icant decrease in the substrate band. In the pres-
ence of 4-FP (e) some turnover is observed, in
agreement with the lower affinity of 4-FP to bind
internally. (f) Inhibition of compound ES forma-
tion (lmax (Soret) ¼ 420 nm) in ferric DHP at
pH 7 due to increasing concentrations of 4-BP.
Biophysical Journal 99(5) 1586–1595
FIGURE 6 Michaelis-Menten analysis of inhibition, showing the initial
reaction velocity versus substrate (2,4,6-TCP) concentration. Assays were
conducted on WT-DHP without the presence of inhibitor, WT-DHP with
125 mM 4-BP, WT-DHP with 250 mM 4-BP, and WT-DHP with 500 mM
4-BP. The Michaelis-Menten fit parameters are given in Table 2.
1592 Thompson et al.inhibition by 4-BP (Fig. 6). The data obtained with and
without 4-BP were fit independently to a Michaelis-Menten
kinetic model. The fit parameters for the kinetic data are
summarized in Table 2. KM increases as the concentration
of inhibitor increases, but Vmax is essentially unchanged
within the limits of the fitting errors. Ideally, one would
use substrate concentrations several times greater than
KM, i.e., [S]max >> KM, but even when 2,4,6-TCP is
used, the substrate solubility remains the limiting factor.
Thus, errors in the fit data arise as KM becomes greater
than [S]max. Although we recognize this limitation, the rela-
tive effect of the inhibitor is clearly observed. Based on
these data, the substrate/inhibitor pair exhibits competitive
inhibition in DHP. Although results of this type cannot be
demonstrated for 2,4,6-TBP because of its limited solubility,
kinetic assays of 2,4,6-TBP with 4-BP under conditions
identical to those used for 2,4,6-TCP with 4-BP yield the
same complete inhibition effect (Fig. S5).DISCUSSION
The shifts in the relative position of 4-XPs bound in the
distal pocket of DHP suggest that there are two driving
forces that stabilize the molecule. First, the parahalogen
atom fills a cavity in the protein. Previous studies have
examined cavities in Mb by determining Xe binding sites
using x-ray crystallography (41). The cavity within DHP
that is filled by the parahalogen is surrounded by hydro-
phobic residues (Fig. S6) and resembles the Xe4 binding
site in sperm whale Mb (41). The second factor is the inter-TABLE 2 Mechaelis-Menten fit parameters
Vmax (mM/s) KM (mM)
No inhibitor 13.15 1.32 1.325 2.11
125 mM 4-BP 15.35 2.94 2.535 6.11
250 mM 4-BP 13.75 4.12 2.805 1.06
500 mM 4-BP 10.45 4.58 3.085 1.71
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and, to a lesser extent, H55 (Fig. 2 c). As the atomic radius
of the halogen decreases, the hydroxyl group moves into
closer contact with H55, Y38, and the heme propionate.
Therefore, as shown in Figs. 2 and 3, a single atom, the para-
halogen X in 4-XP, determines the binding affinity of the
molecule in the distal pocket. Since the bound 4-XP
displaces the water coordinated to the heme iron, one can
also expect that it prevents the coordination of H2O2 and
thereby inhibits peroxidase activity. The finding that
increased concentrations of 4-BP systematically block the
formation of the radical enzymatic intermediate (compound
ES (39); see Fig. 1) in ferric DHP at pH 7 supports this
hypothesis. Moreover, in accord with this hypothesis, the
H55V mutation effectively eliminates the enzymatic
activity of DHP (42).
On the basis of these results, and in agreement with the
known mechanism for the peroxidase family members, we
propose that enzymatic oxidation of substrates such as
2,4,6-TXP (X ¼ I, Br, Cl, F) occurs at an external site.
Recent 1H-15N HSQC experiments on 13C/15N-labeled
DHP clearly indicate different binding interactions between
4-BP inhibitor and 2,4,6-TCP substrate (18). 4-BP binding
causes deviations in the internal binding pocket residues
(F24, F35, F21, H55, and V59; see Fig. S7), whereas
2,4,6-TCP binding affects the distal H55 and amino acids
residing at the protein dimer interface (R122, G1, S129,
and L76; see Fig. S8) (18). Of interest, the common amino
acid that is affected by either binding event, as observed by
NMR, is the distal H55. The combination of RR and NMR
strongly supports the existence of an external substrate-
binding site. Consistent with these observations, every
attempt to infuse 2,4,6-TXPs into the distal pocket in crys-
tals of DHP under conditions identical to those used for the
4-XP x-ray structures resulted in no observable binding.
It appears from the RR data in Fig. 4 that 2,4,6-TFP binds
both externally and internally, which implies that it acts as
substrate and inhibitor, respectively. It is not possible to
directly measure whether 2,4,6-TFP inhibits itself (i.e.,
whether autoinhibition is occurring). However, 2,4,6-TFP
is a poor substrate for DHP compared with 2,4,6-TCP or
2,4,6-TBP, which may be in part due to its propensity to
bind as an inhibitor. Fig. S9 provides a kinetic summary
of the inhibition of 2,4,6-TCP by 2,4,6-TFP. It is clear
from the data that 2,4,6-TFP does in fact inhibit
2,4,6-TCP oxidation. The sigmoidal shape of the 2,6-DCQ
product formation suggests that 2,4,6-TFP is oxidized until
its concentration is reduced such that it no longer acts as an
inhibitor to 2,4,6-TCP oxidation. Several previous binding
studies (16,37,38) used 2,4,6-TFP as a model for the native
substrate because of its high solubility and similar
substitution pattern.
The proposed external active site is consistent with pH-de-
pendent studies of enzyme activity. The greatest activity of
DHP for oxidation of 2,4,6-TCP was observed at pH 7.5
Internal Binding Inhibits DHP 1593(43). Since at this pH, 2,4,6-TCP (pKa 6.4 (44)) is in the
phenolate form, it is unlikely that it would be able to enter
the distal pocket. On the other hand, the pKa of 4-BP is 9.3
(45), so the inhibitor would be protonated and hence neutral
at pH7.5. It is well known that buried charges are not stable in
proteins. Attempts to place a buried charge in Mb by the
mutation V68D resulted in ligation of the negatively charged
carboxylate to the ferric heme iron, thus neutralizing the
charge (46). Hence, neither the structural nor the functional
observations of enzymatic activity are consistent with
substrate binding in the distal pocket, but the same consider-
ations are consistent with the internal binding of 4-bromo-
phenol as an inhibitor. In line with this reasoning, the pKa
of 2,4,6-TFP is ~7.2 (47), the highest of all of the TXPs
studied. Thus 2,4,6-TFP would have the highest percentage
of the phenol form at physiological pH, and therefore the
greatest propensity to enter the distal cavity of the enzyme.
The correlation of the x-ray structural and RR data
elucidates the key role played by the flexibility of the distal
histidine. The x-ray crystal structure of Lebioda et al. (1)
(PDB 1EW6) shows that H55 is in equilibrium between
the open and closed conformations at room temperature.
Nicoletti et al. (16) showed that the n3 band of the RR
spectrum displays an ~40:60 ratio of 5cHS and 6cHS forms.
Binding of 4-XP to DHP forces the distal H55 and H2O out
of the distal pocket (Figs. 1 b, 2 c, and 3 a). Accordingly, the
RR spectra in the presence of 4-XP are typical of 5cHS
heme, indicating that the water molecule has been expelled.
Conversely, the RR spectroscopic data in Fig. 4 and the
UV-vis data in Fig. S3 show that binding of 2,4,6-TXP
increases the population of aquo 6cHS heme. Thus, external
binding of a 2,4,6-TXP substrate forces the distal H55 into
the closed position, stabilizing the heme iron-coordinated
water molecule (Fig. 1 a). Substrate binding, then, enforces
the closed H55 conformation, which strengthens H2O2 coor-
dination to the heme iron and positions H55 to serve as the
acid-base catalyst in the peroxidase mechanism. Further-
more, we have demonstrated that the 5cHS/6cHS ratio can
be driven to either extreme by varying the concentrations
of inhibitor and substrate (Fig. S4), indicating mutual exclu-
sivity between their respective binding sites.
The kinetic data presented in Fig. 6 and Table 2 demon-
strate the competitive nature of the inhibition that occurs
between the substrate-inhibitor pair. The structural and
spectroscopic data presented herein indicate that this unique
mechanism involves two independent but concerted
competitive binding events. The first arises from the steric
interactions of 4-XP binding in the distal pocket preventing
ligation of H2O2 to the heme iron. The second is allosteric
communication by movement of the distal histidine result-
ing in two-site competitive binding between the substrate
and inhibitor pair. Thus, inhibition by 4-XP appears to
involve three simultaneous effects: 1), H2O2 coordination
to the heme iron is impeded; 2), the distal H55, which is
the acid-base catalyst in the peroxidase mechanism(48–50), is displaced out of the cavity; and 3), the external
binding site is subsequently rearranged by the solvent-
exposed (open) distal H55 conformation. Therefore, DHP
exhibits a nonclassical two-site competitive inhibition in
which the inhibitor and substrate have mutually exclusive
binding interactions. When the substrate is bound, the distal
histidine is in the internal, or active, conformation (6cHS),
and the inhibitor cannot access the internal site (see
Fig. 1 a). On the contrary, when the inhibitor is bound, the
distal histidine is in the solvent-exposed, or inactive, confor-
mation (5cHS), and the substrate cannot access the external
site (see Fig. 1 b). The two-site competitive inhibition is
driven by the same open/closed conformational change
that has been studied for many years in Mb (15,24).CONCLUSIONS
Since the x-ray crystal structure of DHP showing the
substrate analog 4-IP bound in the distal pocket (PDB
1EWA) was the first observation of internal binding, it
was reasonable to consider that the internal site may serve
as the active site (1). However, structural, functional, and
spectroscopic studies have repeatedly contradicted that
assumption (17,18,37,38,43,51). The finding that 4-BP and
2,4,6-TBP act as an inhibitor and a substrate, respectively,
for DHP is noteworthy because both molecules are present
in benthic ecosystems (52). However, since 4-BP is not an
oxidation product of 2,4,6-TBP, this inhibitor-substrate
pair is not part of a feedback system for this enzyme.
Organisms such as Notomastus lobatus (among many
others) synthesize 4-BP and 2,4,6-TBP, but this does not
appear to be the case for A. ornata (3,53). Instead, DHP,
which is the most abundant protein in A. ornata, oxidizes
2,4,6-TBP to 2,6-dibromo-1,4-benzoquinone (Fig. 1). The
substrate 2,4,6-TBP acts as both a repellent, protecting
marine organisms from predators, and a potentially lethal
toxin. Therefore, the degradation of 2,4,6-TBP must be
a protective function that minimizes the concentration of
the highly toxic molecule in A. ornata (52). Although the
reason for the inhibition of 2,4,6-TBP oxidation by 4-BP
is not known, it is clear that DHP is a finely tuned enzyme
that has an unusual mechanism for inhibitor specificity.SUPPORTING MATERIAL
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